Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Enalapril Maleate API

Product
  • Therapeutic Category Cardiovascular

  • CAS Number

    76095-16-4

  • API Technology

    Synthetic

  • Dose Form

    Oral Solids, Liquid

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, Korea DMF, Russia DMF

Mechanism of Action

Normally, angiotensin I is converted to angiotensin II by an angiotensin-converting enzyme (ACE). Angiotensin II constricts blood vessels, increasing blood pressure. Enalaprilat, the active metabolite of enalapril, inhibits ACE. Inhibition of ACE decreases levels of angiotensin II, leading to less vasoconstriction and decreased blood pressure

Indication

EPANED is an angiotensin-converting enzyme inhibitor indicated for:

  • Treatment of hypertension in adults and children older than one month, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal ardiovascular events, primarily strokes and myocardial infarctions.
  • Treatment of symptomatic heart failure.
  • Treatment of asymptomatic left ventricular dysfunction, to decrease the rate of development of overt heart failure and reduce hospitalization for heart failure.

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Select Product *
Select Regulatory Requirements
Select Purpose

Related APIs

Fondaparinux Sodico

Cardiovascular

arrow

Treprostinil Olamine

Cardiovascular

arrow

Tafamidis Meglumine

Cardiovascular

arrow

Besilato De Amlodipina

Cardiovascular

arrow

Apixabana

Cardiovascular

arrow

Bempedoic Acid

Cardiovascular

arrow

Clopidogrel Bisulfato (Forma 1)

Cardiovascular

arrow

Bissulfato De Clopidogrel (Forma 2)

Cardiovascular

arrow

Doxazosin Mesylate

Cardiovascular

arrow

Ezetimibe

Cardiovascular

arrow

Lacidipina

Cardiovascular

arrow

Succinato De Metoprolol

Cardiovascular

arrow

Ramipril

Cardiovascular

arrow

Rivaroxabana

Cardiovascular

arrow

Ticagrelor

Cardiovascular

arrow

Losartana De Potássio

Cardiovascular

arrow

Sacubitril Valsartana

Cardiovascular

arrow

Atorvastatina Cálcio (Amorfa)

Cardiovascular

arrow

Mesilato De Etexilato De Dabigatrana

Cardiovascular

arrow

Treprostinil

Cardiovascular

arrow

Valsartana

Cardiovascular

arrow

Tafamidis Free Acid

Cardiovascular

arrow

Aviso legal

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.